Results 11 to 20 of about 118,013 (268)

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines

ESC Heart Failure, 2020
Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca, Marco Sbolli, Marco Metra, Marat Fudim   +3 more
doaj   +1 more source

Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure

BMC Cardiovascular Disorders, 2023
Background Impaired left ventricular function is an independent predictor of adverse clinical outcomes in patients with aortic stenosis. The aim of this study is to evaluate the short-term changes of echocardiographic parameters, New York Heart ...
Mei Dong, Lizhen Wang, Gary Tse, Tao Dai, Lihong Wang, Zhicheng Xiao, Tong Liu, Faxin Ren   +7 more
doaj   +1 more source

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial

ESC Heart Failure, 2022
Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund, Gianluigi Savarese, Ashwin Venkateshvaran, Lina Benson, Anna Lundberg, Erwan Donal, Jean‐Claude Daubert, Emmanuel Oger, Cecilia Linde, Camilla Hage   +9 more
doaj   +1 more source

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction

ESC Heart Failure, 2022
Aims Evidence on the association between ambient temperature and the onset of acute heart failure (AHF) is scarce and mixed. We sought to investigate the incidence of AHF admissions based on ambient temperature change, with particular interest in ...
Takahiro Jimba, Shun Kohsaka, Masao Yamasaki, Toshiaki Otsuka, Kazumasa Harada, Yasuyuki Shiraishi, Shinji Koba, Makoto Takei, Takashi Kohno, Kenichi Matsushita, Tetsuro Miyazaki, Satoshi Kodera, Shigeto Tsukamoto, Kiyoshi Iida, Akito Shindo, Daisuke Kitano, Takeshi Yamamoto, Ken Nagao, Morimasa Takayama, Tokyo CCU Network Scientific Committee   +19 more
doaj   +1 more source

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejection
Marat Fudim, Lin Zhong, Kershaw V. Patel, Rohan Khera, Manal F. Abdelmalek, Anna Mae Diehl, Robert W. McGarrah, Jeroen Molinger, Cynthia A. Moylan, Vishal N. Rao, Kara Wegermann, Ian J. Neeland, Ethan A. Halm, Sandeep R. Das, Ambarish Pandey   +14 more
doaj   +1 more source

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundWorsening renal function (WRF) is associated with adverse outcomes in patients with heart failure. We investigated the predictors and prognostic value of WRF during admission, in patients with preserved ejection fraction (HFpEF) versus those ...
Jeehoon Kang, Jin Joo Park, Young‐Jin Cho, Il‐Young Oh, Hyun‐Ah Park, Sang Eun Lee, Min‐Seok Kim, Hyun‐Jai Cho, Hae‐Young Lee, Jin Oh Choi, Kyung‐Kuk Hwang, Kye Hun Kim, Byung‐Su Yoo, Seok‐Min Kang, Sang Hong Baek, Eun‐Seok Jeon, Jae‐Joong Kim, Myeong‐Chan Cho, Shung Chull Chae, Byung‐Hee Oh, Dong‐Ju Choi   +20 more
doaj   +1 more source

The diagnostic value of peroxisome proliferator-activated receptor-γ coactivator-1α in identifying different chronic heart failure phenotypes

Frontiers in Cardiovascular Medicine, 2022
BackgroundDespite advances in diagnosing and treating chronic heart failure (HF), the underlying mechanisms in different HF phenotypes remain unclear. Mitochondrial energy metabolism is crucial in HF etiology.
Shiwen Zhang, Shiwen Zhang, Yufei Zhou, Yanfang Ma, Zhan Li, Yinglong Hou, Yinglong Hou   +6 more
doaj   +1 more source

Insulin Resistance Is Associated With Heart Failure With Recovered Ejection Fraction in Patients Without Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Because of advances in medical treatments, a substantial proportion of patients with heart failure (HF) have experienced recovery of ejection fraction (EF), termed HF with recovered EF (HFrecEF).
Chen Die Yang, Wen Qi Pan, Shuo Feng, Jin Wei Quan, Jia Wei Chen, Xin Yi Shu, Muladili Aihemaiti, Feng Hua Ding, Wei Feng Shen, Lin Lu, Rui Yan Zhang, Xiao Qun Wang   +11 more
doaj   +1 more source

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review

Терапевтический архив, 2023
Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov, Natalia V. Safronova, Sergey N. Tereshchenko   +2 more
doaj   +1 more source